Skip to main content

Day: February 9, 2021

ClearOne Defeats Shure’s Meritless Preliminary Injunction Motion

SALT LAKE CITY, Feb. 09, 2021 (GLOBE NEWSWIRE) —  ClearOne (NASDAQ: CLRO), a leading global provider of audio and visual communication solutions, today comments on the Order issued by the Honorable Richard G. Andrews of the U.S. District Court of Delaware adopting a Report and Recommendation denying Shure Incorporated’s (“Shure’s”) motion for a preliminary injunction (“PI Motion”) to stop the sale of ClearOne’s innovative Ceiling Tile Beamforming Mic Array (“BMA CT”) and Huddle-compatible Ceiling Tile Beamforming Array (“BMA CTH”) products.ClearOne launched its BMA CT product in February 2019.  In November 2019, ClearOne announced its COLLABORATE® Versa Pro CT product offering, which combines the BMA CTH with the CONVERGE® Huddle audio DSP to provide superior functionality and audio quality for small- to medium-sized rooms.  ClearOne...

Continue reading

OptimizeRx Announces Pricing of Public Offering of Common Stock

ROCHESTER, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and patients, today announced the pricing of the previously announced underwritten public offering of 1,325,000 shares of its common stock at a price to the public of $49.50 per share. The gross proceeds to OptimizeRx from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by OptimizeRx, are expected to be approximately $65.6 million. OptimizeRx granted the underwriters a 30-day option to purchase up to an additional 198,750 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about February 11,...

Continue reading

New Trex® Pergola™ Shadow and Trex® Pergola™ Pavilion Bring Form and Function to Outdoor Living

WINCHESTER, Va., Feb. 09, 2021 (GLOBE NEWSWIRE) — Sleek, sturdy and stylish, the new all-aluminum Trex® Pergola™ Shadow and Trex® Pergola™ Pavilion designs provide the perfect amount of sun, shade and rain protection to accommodate any open-air environment. Joining the already-impressive product lineup from Trex Company, the world’s largest manufacturer of wood-alternative decking and railing, these new shade structures combine form and function, adding a modern take to any outdoor space.“Pergolas and shade structures remain perennially popular due to their versatility, providing protection from the elements, while also adding architectural interest,” said Adam Zambanini, president of Trex Residential Products. “Our Trex decking, railing and accessory options – including Trex Pergola – offer an extensive portfolio of designs and...

Continue reading

Clever Leaves’ Nutraceutical Manufacturer, Herbal Brands Inc., Begins Importing CBD into the US

NEW YORK, Feb. 09, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multi-national operator and licensed producer of pharmaceutical-grade cannabinoids, announced today its branded nutraceutical manufacturer, Herbal Brands, has entered into a strategic partnership with the LooperGroup and TruSource Hemp Group (“TruSource”), a leading provider of services for the hemp industry, to import the Company’s first commercial shipment of CBD into the United States. Clever Leaves´ Colombian facilities are the first and only cannabis operations in LATAM to have a Good Manufacturing Practices certification from the European Union (EU-GMP).“This partnership will capitalize on both Clever Leaves’ and TruSource’s combined expertise within the hemp industry, resulting in...

Continue reading

Herbal Brands Inc, fabricante de nutracéuticos de Clever Leaves, comienza a importar CBD a los Estados Unidos

NUEVA YORK y BOGOTÁ, Feb. 09, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” o la “Compañía”), un operador multinacional líder y productor autorizado de cannabinoides de grado farmacéutico, anunció hoy que su fabricante de nutracéuticos de marca, Herbal Brands, ha establecido una alianza estratégica con Looper Group y TruSource Hemp Group (“TruSource”), un proveedor líder de servicios para la industria del cáñamo, para importar el primer envío comercial de CBD de la Compañía a los Estados Unidos. Las instalaciones de Clever Leaves en Colombia son las primeras y únicas operaciones de cannabis en LATAM que cuentan con una certificación de Buenas Prácticas de Manufactura de la Unión Europea (EU-GMP).“Esta alianza aprovechará la experiencia combinada,...

Continue reading

天演药业宣布确定首次公开发行股价

加利福尼亚州旧金山, Feb. 09, 2021 (GLOBE NEWSWIRE) — 天演药业 (Adagene Inc.)(以下简称“天演药业”或“公司”)(纳斯达克股票代码:ADAG),一家平台驱动型的、致力于创新抗体技术癌症免疫疗法发现和开发的临床阶段生物制药企业,今天宣布确定7,354,000美国存托股票(“ADS”)首次公开发行(“IPO”)的股价,每股美国存托股票为19.00美元。如果承销商不行使其超额配股权来购买任何额外的美国存托股票,则此次IPO的总发行规模约为140.0百万美元。每股美国存托股票代表一又四分之一(1.25)股公司普通股。该ADS已被批准于美国时间2021年2月9日在纳斯达克全球市场开始挂牌交易,股票代码为“ADAG”。在相关惯例交割条件满足后,此次IPO预计将于美国时间2021年2月11日完成交割。公司已授予承销商超额配售权,从最终招股说明书之日起30天内可选择购买累计总数最多为 1,103,100股的额外ADS。Goldman Sachs (Asia) L.L.C.,Morgan Stanley & Co. LLC,Jefferies LLC担任本次发行的联席账簿管理人和承销商代表。China Renaissance Securities (Hong Kong) Limited担任本次发行的联席经理。此次证券登记表已提交给美国证券交易委员会(SEC)并已由其宣布生效。本新闻稿不构成出售或招揽购买要约,如有任何州或司法管辖区的证券法规定在进行登记或取得资格之前的要约、招揽或出售属于非法,则不得在该州或司法管辖区对该证券进行任何出售。本次IPO仅通过构成有效证券登记表一部分的招股说明书进行。此次IPO的最终招股说明书可对外提供后,您可通过联系以下承销商获得招股说明书副本:(1)Goldman & Co L.L.C.,地址:Prospectus Department, 200 West Street,...

Continue reading

Adagene Inc. Announces Pricing of Initial Public Offering

SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies, today announced that it has priced its initial public offering (the “IPO”) of 7,354,000 American depositary shares (“ADSs”), at US$19.00 per ADS. The aggregate offering size of the IPO is approximately US$140.0 million, assuming the underwriters do not exercise their over-allotment option to purchase any additional ADSs. Each ADS represents one and one quarter (1.25) ordinary shares of the Company. The ADSs are expected to begin trading on the Nasdaq Global Market on February 9, 2021 under the ticker symbol “ADAG.”...

Continue reading

iMedia Reports Preliminary Q4 2020 Results and 2021 Guidance

Q4 2020 – Returned to Revenue Growth and Achieved 20% Gross Profit GrowthFull Year 2020 – Positive Operating Cash Flow and Free Cash FlowMINNEAPOLIS, Feb. 09, 2021 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (the “Company”) (NASDAQ: IMBI) is reporting select preliminary unaudited financial results for the fourth quarter ended January 30, 2021, along with recent key company highlights and select guidance for 2021.Preliminary Q4 2020 Results, Company Highlights and 2021 OutlookQ4 net sales are expected to be at least $124.6 million, an increase of at least $1.0 million compared to the same prior-year period and the first time since 20151 that the Company has achieved Q4 revenue growth.Full year 2020 cash flow from operations is expected to be at least $6.0 million compared to $(6.2) million cash used for operations for the same prior-year...

Continue reading

Green Plains Announces Strategic Transactions with BlackRock

OMAHA, Neb., Feb. 09, 2021 (GLOBE NEWSWIRE) — Green Plains Inc. (NASDAQ:GPRE) today announced that funds and accounts managed by BlackRock (“BlackRock”) have invested alongside Ospraie Management and Green Plains in Fluid Quip Technologies LLC. In addition, Green Plains announced the completion of a $125 million, 5-year mezzanine note facility with BlackRock. The proceeds will initially support the construction and deployment of Ultra-High Protein technology and production at Green Plains’ Obion, Tenn. and Mount Vernon, Ind. facilities. As part of the transaction, BlackRock acquired 2,000,000 warrants for Green Plains stock (each warrant equal to one share of stock) with a strike price of $22 per share.“Partnering with BlackRock on the Fluid Quip transaction provides further validation of our strategy and access to substantial capital...

Continue reading

Sharps Compliance Announces Appointment of Pat Mulloy, Veteran CEO of Long-Term and Senior Care Businesses, to Board of Directors

HOUSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, today announced the appointment of William Patrick (Pat”) Mulloy II to its Board of Directors.Mr. Mulloy has more than 20 years of experience in the senior housing and long-term care industry, having led three successful senior housing companies. Most recently he served as Chief Executive Officer of Elmcroft Senior Living, a provider of assisted and independent living, as well as memory and respite care, with over 80 communities in 18 states, which he led from its founding in 2006 through early 2018. From 1996 through early 2000, he served as President and Chief Executive Officer of Atria...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.